Johnson & Johnson Sold Hip Implants Abroad After FDA Rejected Sale In The U.S. For Safety Concerns

Hip Implants Were Sold Overseas After Being Rejected By FDA

The health care products giant Johnson & Johnson continued to market an artificial hip in Europe and elsewhere overseas after the Food and Drug Administration rejected its sale in the United States based on a review of company safety studies.

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE